Lipocine Inc (LPCN)
5.35
+0.11
(+2.10%)
USD |
NASDAQ |
May 10, 16:00
5.35
0.00 (0.00%)
After-Hours: 19:16
Lipocine Shares Outstanding: 5.316M for March 5, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 05, 2024 | 5.316M |
December 31, 2023 | 5.316M |
November 06, 2023 | 5.316M |
September 30, 2023 | 5.316M |
August 08, 2023 | 5.316M |
June 30, 2023 | 5.235M |
May 12, 2023 | 5.206M |
May 09, 2023 | 5.206M |
March 31, 2023 | 5.206M |
March 24, 2023 | 5.206M |
March 07, 2023 | 5.206M |
February 28, 2023 | 5.206M |
December 31, 2022 | 5.206M |
November 07, 2022 | 5.206M |
September 30, 2022 | 5.206M |
August 03, 2022 | 5.206M |
June 30, 2022 | 5.206M |
May 06, 2022 | 5.206M |
April 21, 2022 | 5.206M |
March 31, 2022 | 5.206M |
March 07, 2022 | 5.194M |
December 31, 2021 | 5.194M |
November 09, 2021 | 5.194M |
September 30, 2021 | 5.194M |
August 04, 2021 | 5.194M |
Date | Value |
---|---|
June 30, 2021 | 5.194M |
May 05, 2021 | 5.194M |
April 12, 2021 | 5.194M |
March 31, 2021 | 5.194M |
March 15, 2021 | 5.194M |
March 09, 2021 | 5.194M |
January 28, 2021 | 5.138M |
January 25, 2021 | 4.171M |
January 20, 2021 | 4.171M |
December 31, 2020 | 4.120M |
November 09, 2020 | 3.864M |
September 30, 2020 | 3.864M |
August 20, 2020 | 3.864M |
August 04, 2020 | 3.858M |
June 30, 2020 | 3.610M |
May 06, 2020 | 2.816M |
April 17, 2020 | 2.815M |
March 31, 2020 | 2.815M |
March 15, 2020 | 2.815M |
March 12, 2020 | 2.815M |
February 27, 2020 | 2.808M |
February 25, 2020 | 2.215M |
February 24, 2020 | 2.215M |
December 31, 2019 | 2.215M |
November 18, 2019 | 2.109M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
1.454M
Minimum
Jun 30 2019
5.316M
Maximum
Aug 08 2023
4.209M
Average
5.194M
Median
Mar 09 2021
Shares Outstanding Benchmarks
Alpine Immune Sciences Inc | 65.56M |
Eliem Therapeutics Inc | 27.72M |
NovaBay Pharmaceuticals Inc | 30.10M |
Palatin Technologies Inc | 16.14M |
iBio Inc | 3.484M |